- Home
- VERX vs DAWN Comparison
VERX vs DAWN Comparison
Compare VERX & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VERX | DAWN |
|---|---|---|
| Founded | 1978 | 2018 |
| Country | United States | United States |
| Employees | 2100 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VERX | DAWN |
|---|---|---|
| Price | $13.38 | $21.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | $24.25 | ★ $24.43 |
| AVG Volume (30 Days) | 1.2M | ★ 2.7M |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $748,444,000.00 | $158,182,000.00 |
| Revenue This Year | $12.78 | $55.03 |
| Revenue Next Year | $11.61 | $28.12 |
| P/E Ratio | $302.25 | ★ N/A |
| Revenue Growth | 12.25 | ★ 20.60 |
| 52 Week Low | $10.59 | $5.64 |
| 52 Week High | $42.44 | $21.53 |
Technical Indicators
Market Signals| Indicator | VERX | DAWN |
|---|---|---|
| Relative Strength Index (RSI) | 52.70 | 80.29 |
| Support Level | $11.38 | $10.30 |
| Resistance Level | $13.73 | N/A |
| Average True Range (ATR) | 0.79 | 0.03 |
| MACD | -0.02 | -0.28 |
| Stochastic Oscillator | 38.07 | 90.91 |
Price Performance
Historical ComparisonAbout VERX Vertex Inc.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.